Get the Stockscreener App
11.48
3.12%
0.35
CorMedix Inc stock is traded at $11.48, with a volume of 1.54M.
It is up +3.12% in the last 24 hours and up +1.21% over the past month.
CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
See More
Previous Close:
$11.13
Open:
$11.22
24h Volume:
1.54M
Relative Volume:
0.45
Market Cap:
$896.11M
Revenue:
$65,400
Net Income/Loss:
$-46.34M
P/E Ratio:
-12.48
EPS:
-0.92
Net Cash Flow:
$-38.74M
1W Performance:
+3.87%
1M Performance:
+1.21%
6M Performance:
+22.36%
1Y Performance:
+14.89%
1-Day Range:
$10.87
$11.54
1-Week Range:
$10.87
$11.90
52-Week Range:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Name
CorMedix Inc
Sector
Industry
Phone
908-517-9500
Address
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
11.48 | 872.03M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Jun-30-25 | Downgrade | D. Boral Capital | Buy → Hold |
| Jun-30-25 | Initiated | H.C. Wainwright | Buy |
| Mar-07-25 | Initiated | Leerink Partners | Outperform |
| Jan-13-25 | Initiated | D. Boral Capital | Buy |
| Aug-26-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-17-21 | Initiated | Needham | Buy |
| Sep-29-20 | Initiated | JMP Securities | Mkt Outperform |
| Sep-21-20 | Initiated | Truist | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Mar-26-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-06-18 | Initiated | ROTH Capital | Buy |
| Sep-25-17 | Reiterated | H.C. Wainwright | Buy |
| Aug-10-17 | Reiterated | Rodman & Renshaw | Buy |
| May-05-17 | Reiterated | Rodman & Renshaw | Buy |
| Nov-11-16 | Reiterated | FBR & Co. | Outperform |
| Mar-17-16 | Reiterated | FBR Capital | Outperform |
| Mar-03-16 | Initiated | FBR Capital | Outperform |
| Nov-16-15 | Reiterated | ROTH Capital | Neutral |
| Oct-29-15 | Reiterated | ROTH Capital | Neutral |
| May-06-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-08-14 | Reiterated | ROTH Capital | Buy |
| Oct-03-11 | Downgrade | Maxim Group | Buy → Hold |
View All
CorMedix Inc Stock (CRMD) Latest News
Will CorMedix Inc. stock outperform Nasdaq indexJuly 2025 Retail & Technical Pattern Alert System - newser.com
Will CorMedix Inc. stock benefit from green energy trendsDividend Hike & Low Risk Investment Opportunities - newser.com
Advanced analytics toolkit walkthrough for CorMedix Inc.2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com
Using economic indicators to assess CorMedix Inc. potentialOil Prices & Weekly Watchlist of Top Performers - newser.com
Is CorMedix Inc. stock positioned for digital transformationJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Why CorMedix Inc. (19KA) stock appeals to dividend investorsJuly 2025 Earnings & Verified High Yield Trade Plans - newser.com
Is CorMedix Inc. reversing from oversold territoryMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com
Is CorMedix Inc. (19KA) stock protected from inflationWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
Visual analytics tools that track CorMedix Inc. performanceWeekly Volume Report & Low Risk Entry Point Tips - newser.com
Trend analysis for CorMedix Inc. this weekMarket Movement Recap & AI Powered Market Entry Strategies - newser.com
Could the FDA Approval Spark a New Chapter for CorMedix in 2025? - Yahoo Finance
Should I hold or sell CorMedix Inc. stock in 20252025 Volume Leaders & Real-Time Volume Analysis - newser.com
Applying chart zones and confluence areas to CorMedix Inc.Weekly Profit Report & Verified Entry Point Detection - newser.com
Is CorMedix Inc. (19KA) stock a buy for dividend portfoliosMarket Risk Summary & Expert Verified Movement Alerts - newser.com
Can CorMedix Inc. stock deliver surprise earnings beat2025 Dividend Review & Consistent Return Strategy Ideas - newser.com
Will CorMedix Inc. (19KA) stock profit from AI boomBuy Signal & High Accuracy Buy Signal Tips - newser.com
Reversal indicators forming on CorMedix Inc. stock2025 Top Gainers & Safe Entry Momentum Tips - newser.com
Can CorMedix Inc. stock weather global recessionPortfolio Return Report & Stock Portfolio Risk Management - newser.com
Will CorMedix Inc. stock recover faster than market2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Is CorMedix Inc. stock safe for conservative investorsAnalyst Upgrade & Stepwise Trade Execution Plans - newser.com
Visualizing CorMedix Inc. stock with heatmapsRisk Management & Fast Moving Market Watchlists - newser.com
Will CorMedix Inc. stock sustain high P E ratios2025 Market Trends & Daily Growth Stock Investment Tips - newser.com
CRMD6219746 Bond Coupon Analysis — Rate & Payments - TradingView
Understanding CorMedix Inc.’s price movementMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025 - The Globe and Mail
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - Quiver Quantitative
CorMedix (NASDAQ: CRMD) to report Q3 results; 8:30 a.m. ET call before market open - Stock Titan
Real time alert setup for CorMedix Inc. performanceJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
CorMedix Inc Stock (CRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):